Cutiss is a company that specializes in personalized, bio-engineered, dermo-epidermal skin grafts. It bio-engineers large quantities of individually customized human skin grafts - denovoSkin - starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin is expected to result in a minimally scarring outcome after transplantation. denovoSkin received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.